Evidence map›Paper›PMID 39251928›Full record

ArticleBMC infectious diseases2024

Pan-genome analysis reveals novel chromosomal markers for multiplex PCR-based specific detection of Bacillus anthracis.

Tuvshinzaya Zorigt, Yoshikazu Furuta, Atmika Paudel, Harvey Kakoma Kamboyi, Misheck Shawa, Mungunsar Chuluun, Misa Sugawara, Nyamdorj Enkhtsetseg, Jargalsaikhan Enkhtuya, Badgar Battsetseg and 3 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Whole-genome sequence ofMicrobiology resource announcements · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tuvshinzaya ZorigtDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. tuvshinzaya@czc.hokudai.ac.jp.
Yoshikazu FurutaDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Atmika PaudelDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Harvey Kakoma KamboyiDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Misheck ShawaDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Mungunsar ChuluunDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Misa SugawaraDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Nyamdorj EnkhtsetsegLaboratory of Infectious Diseases and Immunology, Institute of Veterinary Medicine, Mongolian University of Life Sciences, Ulaanbaatar, Mongolia.
Jargalsaikhan EnkhtuyaLaboratory of Food Safety and Hygiene, Institute of Veterinary Medicine, Mongolian University of Life Sciences, Ulaanbaatar, Mongolia.
Badgar BattsetsegLaboratory of Molecular Genetics, Institute of Veterinary Medicine, Mongolian University of Life Sciences, Ulaanbaatar, Mongolia.
Musso MunyemePublic Health Unit, Disease Control Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.
Bernard M Hang'ombeMicrobiology Unit, Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia.
Hideaki HigashiDivision of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.

Funding

Japan Society for the Promotion of Science (JSPS) under Grants-in-Aid for Scientific Research (KAKENHI) 18K19436Japan Society for the Promotion of Science (JSPS) under Grants-in-Aid for Scientific Research (KAKENHI) 21K15430Japan Society for the Promotion of Science (JSPS) under Grants-in-Aid for Scientific Research (KAKENHI) 23K19460The Japan Program for Infectious Diseases Research and Infrastructure (JIDRI) from the Japan Agency for Medical Research and Development (AMED) JP23wm0125008
6 · The paper itself

Abstract

backgroundBacillus anthracis is a highly pathogenic bacterium that can cause lethal infection in animals and humans, making it a significant concern as a pathogen and biological agent. Consequently, accurate diagnosis of B. anthracis is critically important for public health. However, the identification of specific marker genes encoded in the B. anthracis chromosome is challenging due to the genetic similarity it shares with B. cereus and B. thuringiensis.

methodsThe complete genomes of B. anthracis, B. cereus, B. thuringiensis, and B. weihenstephanensis were de novo annotated with Prokka, and these annotations were used by Roary to produce the pan-genome. B. anthracis exclusive genes were identified by Perl script, and their specificity was examined by nucleotide BLAST search. A local BLAST alignment was performed to confirm the presence of the identified genes across various B. anthracis strains. Multiplex polymerase chain reactions (PCR) were established based on the identified genes.

resultThe distribution of genes among 151 whole-genome sequences exhibited three distinct major patterns, depending on the bacterial species and strains. Further comparative analysis between the three groups uncovered thirty chromosome-encoded genes exclusively present in B. anthracis strains. Of these, twenty were found in known lambda prophage regions, and ten were in previously undefined region of the chromosome. We established three distinct multiplex PCRs for the specific detection of B. anthracis by utilizing three of the identified genes, BA1698, BA5354, and BA5361.

conclusionThe study identified thirty chromosome-encoded genes specific to B. anthracis, encompassing previously described genes in known lambda prophage regions and nine newly discovered genes from an undefined gene region to the best of our knowledge. Three multiplex PCR assays offer an accurate and reliable alternative method for detecting B. anthracis. Furthermore, these genetic markers have value in anthrax vaccine development, and understanding the pathogenicity of B. anthracis.

Indexed as

Bacillus anthracisChromosomes, BacterialGenome, BacterialMultiplex Polymerase Chain ReactionAnthraxGenetic MarkersHumansWhole Genome SequencingGenetic MarkersAnthraxBacillus anthracisPan-genomePCRSpecific genes

Identifiers

PMID39251928
PMCPMC11385494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.